6 Dimensions Capital was established in May, 2017 through the merger of Frontline BioVentures and WuXi Healthcare Ventures. The two prominent and experienced teams formed a healthcare focused investment firm with an in-depth focus and extensive coverage both in China and global market.
Website:6dimensionscapital.com/en/teams/
Industries:
Biotechnology
Health Care
Pharmaceutical
Artificial Intelligence
Machine Learning
Therapeutics
Health Diagnostics
Medical
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
Shanghai, Shanghai, China
